Search for katazol in research

Lichen Planopilaris Treated by the Peroxisome Proliferator-Activated Receptor-γ Agonist Pioglitazone: Lack of Lasting Improvement or Cure in the Majority of Patients

research Lichen planopilaris treated by the peroxisome proliferator activated receptor-γ agonist pioglitazone: Lack of lasting improvement or cure in the majority of patients

33 citations , October 2013 in “Journal of The American Academy of Dermatology”

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

In Silico Structure-Based Drug Design Approach To Evaluate Quercetin And Kaempferol As Dual Inhibitors Of JAK3 Kinase And 5-Alpha Reductase Type II With ADMET Profiling

research In Silico Structure-Based Drug Design Approach To Evaluate Quercetin And Kaempferol As Dual Inhibitors Of Jak3 Kinase And 5-Alpha Reductase Type II with ADMET Profiling

June 2026 in “Zenodo (CERN European Organization for Nuclear Research)”

Quercetin and kaempferol may be effective and safe natural treatments for hair loss.

research Tofacitinib citrate alleviates alopecia universalis symptoms in recent case study

April 2016 in “Journal of the American Academy of Dermatology”

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

research Ketoconazole Shampoo for Seborrheic Dermatitis of the Scalp: A Narrative Review

9 citations , August 2024 in “Cureus”

Ketoconazole shampoo is a safe and effective treatment for scalp seborrheic dermatitis.

research Comparative Evaluation of Oral Baricitinib and Tofacitinib in Alopecia Areata: A Retrospective Cohort Study Based on SALT Scores

November 2025 in “Turkish Journal of Dermatology”

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

research Alopecia areata mit gutem Ansprechen auf Tofacitinib

October 2020 in “Der Hautarzt”

Tofacitinib helped regrow hair in a woman with alopecia areata.

Ideal JAK Inhibitor for Alopecia Areata: Baricitinib, Tofacitinib, Ritlecitinib, or Ifidancitinib - Revisiting the Immunomechanisms of the JAK Pathway

research Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway

January 2023 in “Indian Dermatology Online Journal”

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

research A 20-year retrospective clinicopathologic study on melanoma in Singapore

August 2019 in “Journal of The American Academy of Dermatology”

Bleach baths with 0.005% hypochlorite help manage atopic dermatitis by affecting skin cells and reducing itchiness.

research Antibacterials/corticosteroids/minoxidil

February 2023 in “Reactions Weekly”

Experimental Assessment of 3-Meta-Pyridine-1,2,4-Oxadiazole Deoxycholic Acid Derivative as a Prototype of 5-Alpha-Reductase Inhibitors in Silico and in Vivo Models

research Experimental Assessment of 3-meta-Pyridine-1,2,4-Oxadiazole Deoxycholic Acid Derivative as a Prototype of 5-α-Reductase Inhibitors in silico and in vivo Models

January 2023 in “Bioorganičeskaâ himiâ”

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Systematic Review of Newer Agents for the Management of Alopecia Areata in Adults: Janus Kinase Inhibitors, Biologics and Phosphodiesterase-4 Inhibitors

research Systematic review of newer agents for the management of alopecia areata in adults: Janus kinase inhibitors, biologics and phosphodiesterase‐4 inhibitors

12 citations , December 2022 in “JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology”

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

research In Silico Structure-Based Drug Design Approach To Evaluate Quercetin And Kaempferol As Dual Inhibitors Of Jak3 Kinase And 5-Alpha Reductase Type II with ADMET Profiling

June 2026 in “Zenodo (CERN European Organization for Nuclear Research)”

Quercetin and kaempferol may be effective and safe natural treatments for hair loss.

research Upadacitinib Efficacy for the Treatment of Concomitant Psoriasis and Alopecia Areata

December 2023

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

research Diffuse plate-like sheets of desquamation

2 citations , January 2022 in “JAAD Case Reports”

The rash resolved after stopping ponatinib.

research Sustained Scalp, Eyebrow, and Eyelash Hair Regrowth with Ritlecitinib Through Week 48 in Patients with Alopecia Areata: Post-Hoc Analysis of the ALLEGRO Phase 2b/3 Study

November 2023 in “SKIN The Journal of Cutaneous Medicine”

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

research The Emerging Structural Pharmacology of ATP-Sensitive Potassium Channels

5 citations , September 2022 in “Molecular pharmacology”

KATP channels are important for energy balance and are targeted by drugs for diabetes, hypoglycemia, hypertension, and hair loss.

research Psoriatic Alopecia and Paradoxical Psoriasis Induced by Adalimumab Successfully Treated with Certolizumab: Clinical, Trichoscopic, and in vivo Reflectance Confocal Microscopy Features

7 citations , December 2022 in “Skin Appendage Disorders”

Certolizumab effectively treats psoriasis and psoriatic arthritis with fewer side effects than adalimumab.

A Multicenter Placebo-Controlled Clinical Trial on the Efficacy of Oral Ciclosporin A in the Treatment of Canine Idiopathic Sebaceous Adenitis Compared with Conventional Topical Treatment

research A multicentre placebo‐controlled clinical trial on the efficacy of oral ciclosporin A in the treatment of canine idiopathic sebaceous adenitis in comparison with conventional topical treatment

24 citations , May 2010 in “Veterinary dermatology”

Oral ciclosporin A and topical treatments both reduce hair loss and scaling in dogs with sebaceous adenitis, but using both together is most effective.